Subtype
Gestational Trophoblastic Tumor
CI-CAN-00000928GTTExplore in graph →
Non-malignant8 active trials
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00000928GTTExplore in graph →
Clinical trials
61 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06339827 | ASk Questions in GYnecologic Oncology (ASQ-GYO)(ASQ-GYO) | completed | N/A | 68 | Ira WinerOTHER | 1 | Aug 20, 2026 | clinicaltrials |
| NCT03703271 | Study of Hysteroscopic Repeat Curettage as the First-line Treatment in Low-risk Postmolar Gestational Trophoblastic Neoplasia | recruiting | Phase 3 | 70 | Women's Hospital School Of Medicine Zhejiang UniversityOTHER | 1 | Jul 1, 2026 | clinicaltrials |
| NCT06790706 | IMMUNORARE5: A National Platform of 5 Academic Phase II Trials Coordinated by Lyon University Hospital to Assess the Safety and the Efficacy of the IMMUNOtherapy With Domvanalimab + Zimberelimab Combination in Patients With Advanced RARE Cancers(IMMUNORARE5) | active not recruiting | Phase 2 | 27 | Hospices Civils de LyonOTHER | 1 | Jun 25, 2026 | clinicaltrials |
| NCT02834013 | Nivolumab and Ipilimumab in Treating Patients With Rare Tumors | active not recruiting | Phase 2 | 798 | National Cancer Institute (NCI)NIH | 2 | Jun 17, 2026 | clinicaltrials |
| NCT01008501 | Study of the Genetic and Epigenetic Causes of Recurrent Hydatidiform Moles | active not recruiting | — | 100 | Baylor College of MedicineOTHER | 1 | Apr 23, 2026 | clinicaltrials |
| NCT03785574 | Study of Different Therapeutic Strategies in Hydatidiform Mole With Lung Nodule | recruiting | N/A | 30 | Women's Hospital School Of Medicine Zhejiang UniversityOTHER | 1 | Mar 16, 2026 | clinicaltrials |
| NCT05139095 | Camrelizumab Plus Apatinib in Patients With High-risk Gestational Trophoblastic Neoplasia | recruiting | Phase 2 | 70 | Peking Union Medical College HospitalOTHER | 1 | Feb 5, 2026 | clinicaltrials |
| NCT07333326 | Uterine Artery Doppler Flow Velocimetry Parameters for Predicting the Occurrence of Persistent Gestational Trophoblastic Neoplasia After Evacuation of Complete Hydatiform Mole | not yet recruiting | — | 175 | Minia UniversityOTHER | 0 | Jan 12, 2026 | clinicaltrials |
| NCT07202728 | A Multi-center Cohort Study of Hydatidiform Mole in China (CN-HM-01)(CN-HM-01) | recruiting | — | 1,489 | Obstetrics & Gynecology Hospital of Fudan UniversityOTHER | 1 | Oct 2, 2025 | clinicaltrials |
| NCT04562558 | Biweekly Actinomycin-D Treatment or Multi-day Methotrexate Protocol in Low-risk Gestational Trophoblastic Neoplasia | active not recruiting | N/A | 228 | xiang yangOTHER | 1 | Aug 11, 2025 | clinicaltrials |
| NCT06169644 | The Psychological Impact of GTN on Women Who Have Completed Chemotherapy Treatment(PI-GTN) | recruiting | — | 20 | Sheffield Teaching Hospitals NHS Foundation TrustOTHER | 1 | Feb 21, 2025 | clinicaltrials |
| NCT06028672 | Toripalimab Plus Actinomycin-D as Fist-Line Treatment for GTN With FIGO Score 5-6(TA56) | recruiting | N/A | 40 | Peking Union Medical College HospitalOTHER | 1 | Feb 6, 2025 | clinicaltrials |
| NCT06020755 | Toripalimab Plus Actinomycin-D As Fist-Line Treatment for GTN with FIGO Score 7(TA7) | recruiting | Phase 2 | 17 | Peking Union Medical College HospitalOTHER | 1 | Dec 31, 2024 | clinicaltrials |
| NCT04028479 | The Registry of Oncology Outcomes Associated With Testing and Treatment(ROOT) | completed | — | 167 | Taproot HealthINDUSTRY | 1 | Dec 18, 2024 | clinicaltrials |
| NCT06681259 | Clinical Specialty Queue For Gestational Trophoblastic Neoplasia | recruiting | — | 1,000 | Women's Hospital School Of Medicine Zhejiang UniversityOTHER | 1 | Nov 12, 2024 | clinicaltrials |
| NCT05516810 | The Accuracy of Ultrasound Diagnosis of Hydatidiform Moles | unknown | — | 500 | King's College Hospital NHS TrustOTHER | 1 | Jun 11, 2024 | clinicaltrials |
| NCT05635344 | A Feasibility Window Study of Pembrolizumab Prior to Second Evacuation for Post-molar Gestational Trophoblastic Neoplasia | unknown | Phase 2 | 20 | Imperial College LondonOTHER | 1 | Apr 17, 2024 | clinicaltrials |
| NCT06242522 | Fertility and Pregnancy After Avelumab Treatment(FERTILAVE) | unknown | N/A | 50 | Hospices Civils de LyonOTHER | 1 | Mar 15, 2024 | clinicaltrials |
| NCT06284980 | Gestional Trophoblastic Neoplasia Ultrasound Assessment: Titanium Study(TITANIUM) | unknown | — | 120 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 1 | Feb 29, 2024 | clinicaltrials |
| NCT05405192 | Dostarlimab in Chemoresistant Gestational Trophoblastic Neoplasia | withdrawn | Phase 2 | 0 | University of MiamiOTHER | 1 | Feb 28, 2023 | clinicaltrials |
| NCT05637892 | A Cohort Study of Hydatidiform Mole | not yet recruiting | — | 800 | Women's Hospital School Of Medicine Zhejiang UniversityOTHER | 0 | Dec 8, 2022 | clinicaltrials |
| NCT01535053 | Dactinomycin or Methotrexate in Treating Patients With Low-Risk Gestational Trophoblastic Neoplasia | completed | Phase 3 | 57 | GOG FoundationNETWORK | 5 | Aug 12, 2022 | clinicaltrials |
| NCT05203562 | Letrozole as a Prophylaxis From GTN for Complete Mole Patients | unknown | Phase 2 / Phase 3 | 200 | Zagazig UniversityOTHER_GOV | 1 | Jul 12, 2022 | clinicaltrials |
| NCT02639650 | Study of Paclitaxel Plus Cisplatin as the First-line Chemotherapy in High Risk Gestational Trophoblastic Tumor | unknown | Phase 3 | 214 | Weiguo LvOTHER | 1 | Jun 3, 2022 | clinicaltrials |
| NCT04812002 | Study of PD-1 Antibody and Bevacizumab in the Treatment of High-risk GTN After Combined Chemotherapy | unknown | Phase 2 | 20 | Women's Hospital School Of Medicine Zhejiang UniversityOTHER | 1 | Jun 3, 2022 | clinicaltrials |
| NCT04756713 | Second Uterine Evacuation for Low-risk Gestational Trophoblastic Neoplasia(ReCure) | unknown | Phase 3 | 150 | Brigham and Women's HospitalOTHER | 1 | May 27, 2022 | clinicaltrials |
| NCT04047017 | Camrelizumab Combined With Apatinib for Recurrent Resistant GTN(GTN) | completed | Phase 2 | 20 | Peking Union Medical College HospitalOTHER | 1 | Jul 30, 2021 | clinicaltrials |
| NCT01984099 | RCT on the Efficacy of Methotrexate for the Prevention of GTD | completed | Phase 3 | 99 | University of the PhilippinesOTHER | 1 | Apr 17, 2020 | clinicaltrials |
| NCT04303884 | Phase 2 Trial for Chemo-Resistant Gestational Trophoblastic Neoplasias With Pembrolizumab (CR-GTP)(CR-GTP) | unknown | Phase 2 | 15 | CHA UniversityOTHER | 1 | Mar 11, 2020 | clinicaltrials |
| NCT01823315 | Methotrexate Single-dose Treatment and Methotrexate/Actinomycin-D Single-dose Treatment in Low-Risk Gestational Trophoblastic Neoplasia(GTN-01) | unknown | Phase 3 | 300 | Ding MaOTHER | 1 | Dec 24, 2019 | clinicaltrials |
| NCT02096783 | Scripted Sexual Health Informational Intervention in Improving Sexual Function in Patients With Gynecologic Cancer | completed | N/A | 15 | University of Wisconsin, MadisonOTHER | 1 | Nov 18, 2019 | clinicaltrials |
| NCT00651716 | T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant | terminated | — | 150 | Vanderbilt-Ingram Cancer CenterOTHER | 1 | Nov 15, 2019 | clinicaltrials |
| NCT02664961 | Study of TRC105 and Bevacizumab in Patients With Refractory Gestational Trophoblastic Neoplasia (GTN) | terminated | Phase 2 | 3 | Tracon Pharmaceuticals Inc.INDUSTRY | 1 | Jul 23, 2019 | clinicaltrials |
| NCT03885388 | Combination of Methotrexate(MTX) and Actinomycin(ACTD) in the Low Risk Gestational Trophoblastic Neoplasma （GTN） Patients With Score of 5-6 | unknown | Phase 2 / Phase 3 | 300 | Women's Hospital School Of Medicine Zhejiang UniversityOTHER | 1 | Mar 21, 2019 | clinicaltrials |
| NCT01764802 | Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast Cancer | completed | Phase 2 | 100 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | May 30, 2018 | clinicaltrials |
| NCT00003702 | Methotrexate Compared With Dactinomycin in Treating Patients With Gestational Trophoblastic Neoplasia | completed | Phase 3 | 240 | Gynecologic Oncology GroupNETWORK | 1 | May 15, 2018 | clinicaltrials |
| NCT00706875 | A Global Assessment of Medical, Emotional and Reproductive Concerns in Gestational Trophoblastic Disease Survivors | completed | — | 59 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 30, 2018 | clinicaltrials |
| NCT00096187 | Pemetrexed Disodium in Treating Patients With Recurrent or Persistent Low-Risk Gestational Trophoblastic Tumor After a Molar Pregnancy | terminated | Phase 2 | 55 | Gynecologic Oncology GroupNETWORK | 1 | Apr 12, 2018 | clinicaltrials |
| NCT03280979 | Rescue Regimen and High Dose Methotrexate in Management of Presistent Gestational Trophoplastic Neoplasia | unknown | Phase 2 / Phase 3 | 170 | Assiut UniversityOTHER | 0 | Sep 13, 2017 | clinicaltrials |
| NCT00521118 | Second Curettage in Treating Patients With Persistent Non-metastatic Gestational Trophoblastic Tumors | completed | Phase 2 | 64 | Gynecologic Oncology GroupNETWORK | 2 | Aug 24, 2017 | clinicaltrials |
| NCT00324324 | Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant | terminated | Phase 3 | 240 | OHSU Knight Cancer InstituteOTHER | 1 | May 9, 2017 | clinicaltrials |
| NCT00900068 | Blood Samples From Patients on a Clinical Trial to CINV During HSCT | terminated | — | 9 | OHSU Knight Cancer InstituteOTHER | 1 | May 9, 2017 | clinicaltrials |
| NCT02606539 | Surgery Plus Single Agent Chemotherapy Versus Primary Chemotherapy for Gestational Trophoblastic Neoplasms(SVCGTN) | unknown | Phase 2 / Phase 3 | 20 | Maher elesawi kamel elesawiOTHER | 1 | Mar 22, 2017 | clinicaltrials |
| NCT00897442 | Collecting Tumor Samples From Patients With Gynecological Tumors | completed | — | 275 | Gynecologic Oncology GroupNETWORK | 1 | Oct 28, 2016 | clinicaltrials |
| NCT02892877 | The French National Reference Centre of GTD(French GTDC) | recruiting | — | 25,500 | Hospices Civils de LyonOTHER | 1 | Sep 8, 2016 | clinicaltrials |
| NCT01630954 | A Comparison of Single Versus Double Evacuation for Treatment of Hydatidiform Mole | unknown | Phase 4 | 120 | Nilratan Sircar Medical CollegeOTHER_GOV | 1 | Mar 23, 2016 | clinicaltrials |
| NCT00293384 | Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant | completed | N/A | 40 | Barbara Ann Karmanos Cancer InstituteOTHER | 1 | Mar 15, 2016 | clinicaltrials |
| NCT01764789 | Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer | completed | N/A | 39 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Oct 9, 2015 | clinicaltrials |
| NCT00003107 | Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors | completed | Phase 1 | — | Indiana UniversityOTHER | 1 | Sep 10, 2014 | clinicaltrials |
| NCT00058071 | Amifostine in Treating Peripheral Neuropathy in Patients Who Have Received Chemotherapy for Cancer | completed | Phase 3 | 100 | Gynecologic Oncology GroupNETWORK | 1 | Jul 9, 2013 | clinicaltrials |
Data updated 22 days agoSource updated Aug 20, 2026source: clinicaltrials